Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir (RALBAT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Turin, Italy
Sponsor:
Collaborators:
University of Turin, Italy
University of Milan
Information provided by (Responsible Party):
Giovanni Di Perri, University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT01902186
First received: July 10, 2013
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)